Shunt and method treatment of glaucoma

• US 7,947,008 B2
• Filed: 08/12/2008
• Issued: 05/24/2011
• Est. Priority Date: 05/29/2002
• Status: Expired due to Fees

• Current Assignee: University Of Saskatchewan
• Original Assignee: University Of Saskatchewan
• Inventors: Stilling, Denise Sharon, Grahn, Bruce Harold, Storey, Eric Shad
• Primary Examiner(s): Deak; Leslie R
• Application Number:
  US12/190,211
• Publication Number:
  US 20090036818A1
• Time in Patent Office: 1,015 Days
• Field of Search: 604 7- 10, 604/27, 604/28, 604/30, 604/264, 604/521, 604/289, 606/153
• US Class Current: 604/9
• CPC Class Codes: A61F 9/0017 implantable in, or in contact with, the eye, e.g. ocular inserts
• CPC Class Codes: A61F 9/00781 Apparatus for modifying intraocular pressure, e.g. for glaucoma treatment drainage implants in general A61M27/002
• CPC Class Codes: A61M 2210/0612 Eyes
• CPC Class Codes: A61M 27/002 Implant devices for drainage of body fluids from one part of the body to another intraocular A61F9/00781; middle ear A61F11/202
• CPC Class Codes: A61M 39/22 Valves or arrangement of valves A61M39/02, A61M39/0247, A61M39/16 take precedence; regulating valves in infusion systems A61M5/16881; in devices worn by the patient for the reception of urine, faeces, catamenial or other discharge, or in colostomy devices A61F5/4405

Abstract

This invention provides a shunt for implantation between the anterior chamber of the eye and the epithelial-lined space through the frontal sinus bone of a patient for the treatment of glaucoma. The shunt includes a tube having a length sufficient to span the distance between the anterior chamber of the eye and the epithelial-lined space of the patient, the tube having an open anterior chamber end and a closed epithelial-lined space end, and a seal device associated with the tube between the anterior chamber and epithelial-lined space ends, for sealing a hole in the frontal sinus bone, and for anchoring the tube against movement from the frontal sinus bone. The shunt also includes a fluid pressure openable valve in the tube, located at or near the epithelial-lined space sinus end, allowing for controlled flow of aqueous humor through the tube when implanted. The invention also extends to a method of treating glaucoma in a patient by surgically implanting the shunt between the anterior chamber of the eye and the frontal sinus.

Claims

1. A shunt for implantation between the anterior chamber of the eye and the epithelial-lined space through the frontal sinus bone of a patient for the treatment of glaucoma, comprising:

a tube having a length sufficient to span the distance between the anterior chamber of the eye and the epithelial-lined space of the patient, the tube having an open anterior chamber end and a closed epithelial-lined space end;

a seal device associated with the tube between the anterior chamber and epithelial-lined space ends, for sealing a hole in the frontal sinus bone, and for anchoring the tube against movement from the frontal sinus bone;

a fluid pressure openable valve in the tube, the valve being located at or near the epithelial-lined space end of the tube such that when implemented the valve is within the epithelial-lined space, allowing for controlled flow of aqueous humor through the tube, the valve including a longitudinal slit in the tube; and

one or more ligature devices around the tube overlying or adjacent the slit wherein at least one ligature device overlies the slit so that adjustment of the one or more ligature devices adjusts fluid flow through the valve, the one or more ligature devices tighten the slit allowing less fluid to escape from the tube and drain from the anterior chamber.

2. The shunt of claim 1, wherein the epithelial-lined space is the frontal sinus, and the closed end of the tube is thus the frontal sinus end.

3. The shunt of claim 2, further comprising a reservoir located at the closed frontal sinus end of the tube, said reservoir having a side wall forming one or more apertures through which fluid can flow from the tube, and wherein the pressure openable valve is located in the reservoir.

4. The shunt of claim 1, wherein the seal device comprises a widened portion of the tube, or a pliable spool-shaped plug fixed to the tube and through which the tube is threaded, said plug having upper and lower pliable flanges which seal on either side of the hole in the frontal sinus bone and which prevent movement of the plug relative to the frontal sinus bone, the upper flange being anterior chamber facing and being sufficiently pliable to be slid through the hole in the frontal sinus bone.

5. The shunt of claim 1, wherein the seal device or plug bends the tube through an angle sufficient to prevent kinking of the tube as it is implanted between the anterior chamber and the frontal sinus.

6. The shunt of claim 5, wherein the seal device or plug bends the tube through an angle of between 80 and 100°

.

25. A method of treating glaucoma in a patient, comprising:

forming a hole from the exterior into the epithelial-lined space of the patient;

surgically implanting through the hole, between the anterior chamber and the epithelial-lined space, a shunt as defined in claim 1; and

draining aqueous humor from the anterior chamber through the shunt to the epithelial-lined space.

7. A shunt for implantation between the anterior chamber of the eye and an epithelial-lined space of a patient for the treatment of glaucoma, comprising:

a tube having a length sufficient to span the distance between the anterior chamber of the eye and the epithelial-lined space of the patient, the tube having an open anterior chamber end and an epithelial-lined space end;

a seal device associated with the tube between the anterior chamber and epithelial-lined space ends to seal and anchor the tube against movement once implanted;

an adjustable valve in the tube to control flow of aqueous humor through the tube when implanted, the valve including a longitudinal slit in the tube; and

a plurality of ligature devices around the tube at the slit, at least one of the ligature devices overlying the slit such that adjustment of the at least one of the ligature devices adjusts fluid flow through the valve.

8. The shunt of claim 7, wherein the valve is adjustable to open and close to maintain a desired intraocular pressure for the patient.

9. The shunt of claim 8, wherein the tube has a length sufficient to span the distance between the anterior chamber and the epithelial-lined space selected from the maxillary sinus, nasal sinus, respiratory sinus or space, subdural space or meningeal cavity.

10. The shunt of claim 9, wherein the valve is located at or near the epithelial-lined space end of the tube.

11. The shunt of claim 10, wherein the epithelial-lined space is the frontal sinus, and the epithelial-lined space end of the tube is thus the frontal sinus end.

12. The shunt of claim 11, wherein the valve is fluid pressure openable.

13. The shunt of claim 12, wherein the frontal sinus end of the tube is closed.

14. The shunt of claim 11, wherein the shunt further comprises a reservoir located at the frontal sinus end of the tube, said reservoir having a side wall forming one or more apertures through which fluid can flow from the tube, and wherein the valve is located in the reservoir.

15. The shunt of claim 11, wherein the seal device comprises a widened portion of the tube, or a pliable spool-shaped plug fixed to the tube and through which the tube is threaded, said plug having upper and lower pliable flanges which seal on either side of a hole in the frontal sinus bone and which prevent movement of the plug relative to the frontal sinus bone, the upper flange being anterior chamber facing and being sufficiently pliable to be slid through the hole in the frontal sinus bone.

16. The shunt of claim 15, wherein the seal device or the plug bends the tube through an angle sufficient to prevent kinking of the tube as it is implanted between the anterior chamber and the frontal sinus.

17. The shunt of claim 16, wherein the seal device or the plug bends the tube through an angle of between 80 and 100°

.

26. A method of treating glaucoma in a patient, comprising:

forming a hole from the exterior into the epithelial-lined space of the patient;

surgically implanting through the hole, between the anterior chamber and the epithelial-lined space, a shunt as defined in claim 7; and

draining aqueous humor from the anterior chamber through the shunt to the epithelial-lined space.

18. A shunt for implantation between the anterior chamber of the eye and the frontal sinus of a patient for the treatment of glaucoma, comprising:

a tube having a length sufficient to span the distance between the anterior chamber of the eye and the frontal sinus of the patient, the tube having a tube end and a valved frontal sinus end;

a seal component on the tube spaced from the frontal sinus end to hold the tube in place in the frontal sinus;

a slit extending longitudinally in the tube and located at the frontal sinus end, allowing for flow of aqueous humor through the tube when implanted; and

a plurality of ligature devices around the tube at the slit to wherein at least one ligature device overlies the slit control flow through the slit.

19. The shunt of claim 18, wherein the seal component bends the tube to prevent kinking of the tube as it is implanted between the anterior chamber and the frontal sinus.

20. The shunt of claim 18, wherein the tube is formed of silicone.

21. The shunt of claim 18, wherein the tube has an internal diameter of between 0.25 and 0.64 mm.

22. The shunt of claim 18, wherein the ligature devices are mounted circumferentially around a longitudinal axis of the slit and snug enough to slightly indent the tube without disturbing an orientation of the slit.

23. The shunt of claim 18, wherein the ligature devices are formed of a biocompatible material.

24. The shunt of claim 18, wherein the ligature devices are selected from the group consisting of circumferential sutures, metal C-shaped clamps, plastic round O-rings, silicone round O-rings, and rubber round O-rings.

27. A method of treating glaucoma in a patient, comprising:

forming a hole from the exterior into the epithelial-lined space of the patient;

surgically implanting through the hole, between the anterior chamber and the epithelial-lined space, a shunt as defined in claim 18; and

draining aqueous humor from the anterior chamber through the shunt to the epithelial-lined space.